Keensight Capital invests in AstraZeneca spin-out
The deal will boost CatSci’s ability to deliver best-in-class medicines to patients worldwide - News - PharmaTimes
Source: pharmatimes.com
Stay updated with breaking news from Keensight . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The deal will boost CatSci’s ability to deliver best-in-class medicines to patients worldwide - News - PharmaTimes